Development of a rubella vaccination strategy: Contribution of a rubella susceptibility study of women of childbearing age in Kyrgyzstan, 2001

Clinical Infectious Diseases

Volumn 38, Issue 12, 2004, Pages 1780-1783

  Malakmadze, Naile ^a,e   Zimmerman, Laura A ^a   Uzicanin, Amra ^a   Shteinke, Luidmila ^c   Caceres, Victor M ^a   Kasymbekova, Kaliya ^c   Sozina, Irina ^d   Glasser, John W ^a   Joldubaeva, Mira ^c   Aidyralieva, Chinara ^d   Icenogle, Joseph P ^b   Strebel, Peter M ^a   Reef, Susan E ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c Ministry of Health of the Kyrgyz Republic   (Kyrgyzstan)

^d U Nations Children's Fund Office   (Kyrgyzstan)

^e NONE   (Georgia)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; RUBELLA VACCINE;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HEALTH PROGRAM; HUMAN; INFECTION SENSITIVITY; KYRGYZSTAN; MAJOR CLINICAL STUDY; PREGNANCY; PRIORITY JOURNAL; RUBELLA;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; FEMALE; HUMANS; IMMUNITY, ACTIVE; KYRGYZSTAN; RUBELLA; RUBELLA VACCINE; RUBELLA VIRUS; VACCINATION;

EID: 2942693559     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/421018     Document Type: Article

References (13)

1. Cutts FT, Vynnycky E. Modelling the incidence of congenital rubella syndrome in developing countries. Int J Epidemiol 1999; 28:1176-84.
2. De la Mata I, De Wals P. Policies for immunization against rubella in European countries. Eur J Epidemiol 1988; 4:175-80.
3. Hinman AR, Bart KJ, Orenstein WA, Preblud SR. Rational strategy for rubella vaccination. Lancet 1983; 1:39-40.
4. Preventing congenital rubella syndrome. Wkly Epidemiol Rec 2000; 75:290-5.
5. Dayan GH, Zimmerman L, Shteinke L, et al. Investigation of a rubella outbreak in Kyrgysstan in 2001: implications for an integrated approach to measles elimination and prevention of congenital rubella syndrome. J Infect Dis 2003; 187(Suppl 1):S235-S240.
6. Enders-Ruckle G. Seroepidemiology of rubella and reinfection. Amer J Dis Child 1969; 118:139-42.
7. World Heath Organization. Guidelines for surveillance of congenital rubella syndrome (CRS) and rubella. Geneva: WHO, Department of Vaccines and Other Biologicals, 1999.
8. Pebody RG, Edmunds WJ, Conyn-van Spaendonck M, et al. The seroepidemiology of rubella in western Europe. Epidemiol Infect 2000; 125:347-57.
9. Cutts FT, Robertson SE, Diaz-Ortega JL, Samuel R. Control of rubella and congenital rubella syndrome (CRS) in developing countries. I. Burden of disease from CRS. Bull World Health Organ 1997; 75:55-68.
10. Semerikov VV, Popov VF, Sedel'nikova TA, et al. Rubella in Russia: the detection of congenital rubella and the vaccination strategy and procedures [in Russian]. Zh Mikrobiol Epidemiol Immunobiol 1998: 46-9.
11. Knox EG. Theoretical aspects of rubella vaccination strategies. Rev Infect Dis 1985; 7(Suppl 1):S194-S197.
12. Robertson SE, Cutts FT, Samuel R, Diaz-Ortega JL. Control of rubella and congenital rubella syndrome (CRS) in developing countries. II. Vaccination against rubella. Bull World Health Organ 1997; 75:69-80.
13. Hinman AR, Irons B, Lewis M, Kandola K. Economic analyses of rubella and rubella vaccines: a global review. Bull World Health Organ 2002; 80:264-70.